Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
The mutations and deregulation of Wnt signaling pathway occur commonly in human cancer and cause the aberrant activation of β-catenin and β-catenin-dependent transcription, thus contributing to cancer development and progression. Therefore, β-catenin has been demonstrated as a promising target for c...
Saved in:
Main Authors: | Wen-Kai Yu (Author), Zhi-Yuan Xu (Author), Li Yuan (Author), Shaowei Mo (Author), Beihua Xu (Author), Xiang-Dong Cheng (Author), Jiang-Jiang Qin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis, Characterization, Cellular Uptake, and In Vitro Anticancer Activity of Fullerenol-Doxorubicin Conjugates
by: Beihua Xu, et al.
Published: (2021) -
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
by: Si-Min Qi, et al.
Published: (2021) -
Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
by: Jiayun Xu, et al.
Published: (2022) -
Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice
by: Jia Zhang, et al.
Published: (2020) -
Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy
by: Jiang-Jiang Qin, et al.
Published: (2018)